#artpr

[theworkshopn4]

1 3. S O H O. S Q U A R E I need your help! For this residency I am asking for you to gift me a rock. Any rock. A bit of discarded brick or concrete. A small stone. A pebble. Or maybe you have something more exotic you’d like to donate? I need as many as I can get between now and 22nd March. Why? I hear you ask! Well I’m creating new works made from the pigment of rocks gifted to me and I’ll also be creating a collaborative installation for the end of residency exhibition. How? I hear you ask! (Don’t pretend you’re not interested in rocks) you can either bring me your rocks in person or you can post them to: FAO Lisa-Marie Price 13 Soho Square London W1D 3QF If you post them please let me know who you are, a return address so I can send you a thank you note (optional) and where you found the rock. All donors will be added to a list of names that will be credited at the final exhibition. If you’re coming in person please DM me first so we can arrange a day:time. Don’t leave me hanging guys, help a girl out. Spread the word. Encourage all you know to get involved please!! 🪨🤘🏼🙏🏼✌🏼 #collaborativeart #inclusiveart #artinstallation #artcritic #londonart #sohosquare #sohoartgsllery #artresidency #rockmail #abstractartist #artjournalist #artpr https://www.instagram.com/p/CorsF4MIC-q/?igshid=NGJjMDIxMWI=

[little-ol-brisey]

My Midnights drawing and the process :) This is my first time I dip my toes into fan art but I wanted to preserve the stars that came with the Midnights vinyl.

[icouldntfindquiet]

catfishandthebottlemen PRE SALE TICKETS HERE - https://www.ticketmaster.co.uk/event/3E00613BA14212D4?did=artpre

[pilloclock]

https://www.ticketmaster.co.uk/event/3E00616BCDAA221F?did=artpre&fbclid=IwZXh0bgNhZW0CMTEAAR1yMSBWIMGndw3bLO4UyJZsluam4LrqWDQ9MlVhU7eAu9wfMxFKolhQ-0A_aem_54R6TDpI_jyobydvVL1PHQ

[beautifulbizarremagazine]

Cute sculpture by @tachpollard⁣ .⁣ Tach was a finalist in the 2019 Beautiful Bizarre Art Prize, Sculpture Award. To find out more about the 2020 Art Prize visit https://ift.tt/2Sxxyq2 (link in bio)⁣ .⁣ .⁣ .⁣ posted on Instagram - https://instagr.am/p/CBQgp3wgWq2/

[jorgeriveracardona]

“Yearning for normality”, 2020 #painting #art #covid19 #contemporaryart #puertorico #fuck #artagentneedit #artgallery #artmoma #quarentine #beyondwalls #lonely #artny #artpr #artps1 #artmiami #artbasel #artindoor https://www.instagram.com/p/B_QGZqWBwkb/?igshid=nbkxpc36r0pc

[marcusdoveart]

Big thank you @greatcentral @artbaby_eah @walshypictures for making this interview look good 💥 Cheers @scolesphoto for bringing out my dashing smile in the 'proud mother' shot 😅 . . #art #pr #publicrelations #pressrelease #wip #abstractart #modernart #contemporaryart #marcusdove #artwork #magazine #smile #artgallery #artstudio #artnews #magazine #artist #curator #liveart #newart #guerillaart #photography #weaponry #bomb #greatcentral #performanceart #artfair #artpr #press

[annasavart]

[crafttrap]

🏁🏁🏁🔺🔺🔺 . . #crafttrap #fortheculturebytheculture #craftt #atlantaart #artofatlanta #nashvillearts #InternationalArt #FineArt #ArtCollector #LAtimes #NYtimes #ArtandCulture #ArtBlog #ContemporaryArt #ArtsBlogger #ArtMagazine #ArtPr #ArtPublication #HipHop #Trap #TrapMusic #Culture #MagazineEditorial #WriterOfInstagram #ArtistsOnInstagram #BlackArt #LA #LaGallery #ArtEditor #artbasel https://www.instagram.com/p/BxxIeOBFHCp/?igshid=1rl6rgtf2xgzs

[gravityblue]

http://bit.ly/2VOjIns

Photo By Kaz | Pixabay #pawprint #pawprints #background #printdesign #artprints #printingdesign #cats,dogs #artprint #pinkprint http://bit.ly/2LqNpHg

[theworkshopn4]

R E S I D E N C Y My first ever residency will be at this amazing location in Soho Square!! Officially starting tomorrow I will be working from here for 6 weeks with 7 other artists, leading up to a closing exhibition on Thursday 23rd March. Put it in your diary now! You won’t want to miss it! I will be holding open studios, talks and workshops. Dates/times to come. If you would like to visit just drop me a DM. All I ask is that you bring me a rock. Any rock, any size, any type , any colour. It’ll be used in either an installation or if I can, I’ll use it to make paint. You will be part of my work and your name will be added to a list to go alongside the work. If you can’t visit but want to send me a rock in the post PLEASE DO!! Who doesn’t love Mail and especially (for me) rocks and collaboration. Please help me spread the word and share this post. Address for rock mail is: FAO Lisa-Marie Price 13 Soho Square London W1D 3QF Pop your rock in an envelope with a note telling me who you are, return address if you would like a little thank you note and where you found the rock please ☺️ Help me make this happen! SHARE SHARE SHARE PLEASE #collaborativeart #inclusiveart #artinstallation #artcritic #londonart #sohosquare #sohoartgsllery #artresidency #rockmail #abstractartist #artjournalist #artpr (at 13 Soho Square) https://www.instagram.com/p/Cokny36oVGW/?igshid=NGJjMDIxMWI=

[shopsui]

I’m looking forward to working today at @cambridgestudiogallery for the @loribellespirovski #artopening from 2-4 pm The gallery opens at 12 pm. Now that there’s no more #Shopsui, I’m channeling my energies into an #artgallery and #galleryshop for your gifts #mothersday and #birthdaygifts! See you today! I’ll be at 52 Cambridge st from 1 pm and again next Wed 12 to 5 pm #shoplocal #socialmedia #artPR (at Cambridge Studio Gallery)

[rootsanalysis-blog]

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%

Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future

 Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings.

 The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories soon.

 To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html

 Key Market Insights

 260 therapy candidates are currently in different phases of development

Nearly 25% of pipeline drugs are in the clinical phase of development, while the rest are in the preclinical / discovery stage. Interestingly, most of these drugs target digestive and gastrointestinal disorders (20%); this is followed by product candidates intended for treatment of oncological disorders (17%) and infectious diseases (13%).

 Over 30 microbiome diagnostic tests are currently available / under development

Around 30% of the abovementioned tests have been commercialized, while the rest are under development. Of the total tests, notable examples of companies that launched a microbiome-based diagnostic solution include (in alphabetical order) ARTPred, Genetic Analysis, Goodgut, Invivo Healthcare, IS-diagnostics, Luxia Scientific and Varinos.

 FMTs are the only commercially available microbiome therapy

This therapeutic product is presently indicated for the treatment of recurrent Clostridium difficile infections (rCDIs). Further, non-industry players (such as University of Alberta, The Second Hospital of Nanjing Medical University, University of California and Chinese University of Hong Kong) are making notable contributions in this arena, having been involved in ~200 clinical trials till August 2019.

 51% growth in capital investments has been observed since 2015; around 70% investment has come from Venture Capital investors

It is worth noting that more than 80 investors have supported the R&D programs initiated by start-ups focused on microbiome-related products.  Well-funded start-ups have initiated product development programs, having invested significant time and effort to explore the applicability of microbiome therapeutics across various indications.

 North America and Europe are anticipated to capture over 85% of the market share by 2030

As late stage products are commercialized, the microbiome therapeutics market is likely to grow at an annualized growth rate of over 30%, during the next decade. In addition to North America and Europe, the market in China / broader Asia Pacific region is also anticipated to grow at a relatively faster rate.

 To request a sample copy / brochure of this report, please visit this- https://www.rootsanalysis.com/reports/281/request-sample.html

 Key Questions Answered

§  Who are the leading developers of microbiome therapeutics and diagnostic tests?

§  What are the key technology platforms (available / under development) for microbiome-related therapies and diagnostics?

§  What are the disease indications against which microbiome-based therapeutics are being evaluated?

§  Which companies are targeting gut-brain axis for the development of microbiome therapies?

§  Who are the leading (industry and non-industry) players involved in the development of FMT products?

§  Who are the key contract research / manufacturing service providers in this domain?

§  What is the trend in capital investments in microbiome-related R&D?

§  What are the contributions of big pharma players in this domain?

§  Which are the popular players offering big data-related services / tools to support microbiome research?

§  How is the current and future market opportunity for microbiome-based therapeutics and diagnostics is likely to be distributed across key market segments?

  The USD 4 billion (by 2030) financial opportunity within the microbiome therapeutics (Tx) market and diagnostics (Dx) markets, has been analyzed across the following segments:

§  Type of Therapy (Tx)

§  Prescription Drug

§  Prebiotics

§  Probiotics

 §  Type of Molecule (Tx)

§  Small Molecules

§  Biologics

 §  Target Indication (Tx+Dx)

§  Acne Vulgaris

§  Atopic Dermatitis

§  Clostridium difficile Infection

§  Colorectal Cancer

§  Crohn’s Disease

§  Diabetes

§  Irritable Bowel Syndrome

§  Lactose Intolerance

§  Lung Cancer

§  Nonalcoholic steatohepatitis (NASH)

§  Obesity

§  Ulcerative colitis

 §  Therapeutic Area (Tx+Dx)

§  Autoimmune Disorders

§  Dental Disorders

§  Digestive and Gastrointestinal Disorders

§  Dermatological Disorders

§  Infectious Disease

§  Metabolic Disorders

§  Oncology

§  Others

 §  Key Geographical Regions (Tx+Dx)

§  North America

§  Europe

§  Asia-Pacific and Rest of the World

 The report features inputs from eminent industry stakeholders, according to whom innovation in microbiome-related research is mostly being driven by start-ups / small-sized companies. The report includes detailed transcripts of discussions held with the following experts:

§  Veronika Oudova (Co-founder and Chief Executive Officer, S-Biomedic)

§  Colleen Cutcliffe (Co-founder and Chief Executive Officer, Whole Biome)

§  Lee Jones (President and Chief Executive Officer, Rebiotix)

§  Mark Heiman (Chief Scientific Officer and Vice President, Research, MicroBiome Therapeutics)

§  Assaf Oron (Chief Business Officer, BiomX)

§  Pierre-Alain Bandinelli (Chief Business Officer, Da Volterra)

§  Nikole E Kimes (Co-founder and Vice President, Siolta Therapeutics)

§  James Burges (Executive Director, OpenBiome)

§  JP Benya (Vice President, Business Development, Assembly Biosciences)

§  Debbie Pinkston (Vice President, Sales and Business Development, List Biological Laboratories)

§  Gregory J Kuehn (Vice President, Business Development and Marketing, Metabiomics)

§  Alexander Segal (Vice President, Business Development, Universal Stabilization Technologies)

§  Alexander Lin (Associate General Manager, Chung Mei Pharmaceutical)

§  Aaron Wright (Senior Scientist, Pacific Northwest National Laboratories)

 The research covers detailed profiles, featuring a brief company overview, its financial information (if available), product portfolio details (such as status of development of pipeline candidates, clinical trial information and analysis of key trial end-points), recent developments and an informed future outlook.

§  4D Pharma

§  Armata Pharmaceuticals

§  Evelo Biosciences

§  Rebiotix (Acquired by Ferring Pharmaceuticals)

§  Seres Therapeutics

§  Vedanta Biosciences

 For additional details, please visit 

https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or email sales@rootsanalysis.com

 You may also be interested in the following titles:

1.     Antibody Drug Conjugates Market (5th Edition), 2019-2030

2.     Gene Therapy Market (3rd Edition), 2019 - 2030

3.     Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030

4.     Synthetic Lethality-based Drugs and Targets Market, 2019-2030

 Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

[foxgodknows]

ｰｰ

**イギリス公演開催決定DEATH！！**

Posted : 2019.04.23

O2 Brixton Academy（イギリス・ロンドン）でゲストバンドを迎えたスペシャルライブが決定しました。

スウェーデン出身のメタルバンドAMARANTHEとミステリアスなマスクが印象的なロンドン出身 ミュージック・コレクティブSLEEP TOKENをゲストに迎えてO2 Brixton Academyでライブを開催します。

＜イベント詳細＞

7月2日（火）O2 Brixton Academy / ロンドン・イギリス

Guest: AMARANTHE / SLEEP TOKEN

BABYMETAL プレセール: 4月 24(水）10:00am （現地時間）(password:BM2019)

→ [MyTicket.co.uk][]

一般 : ４月26日（金）10:00am （現地時間）

→ [MyTicket.co.uk][MyTicket.co.uk 1]

[MyTicket.co.uk]: https://myticket.seetickets.com/event/babymetal/o2-academy-brixton/1369098?pre=artpre&src=artistpresale

[MyTicket.co.uk 1]: https://myticket.seetickets.com/event/babymetal/o2-academy-brixton/1369098?offercode=babymetalvip&src=babymetalvip

[marcusdoveart]

Being a mess is a good indicator of productivity. Last night was stress, the battery in the missile launcher went dead before I even begun 🚀 Now I'm a clean 10 hours behind schedule ⌛⌛⌛ . . 'I'm forever dirt' - MM . . #art #wip #abstractart #modernart #contemporaryart #marcusdove #startartfair #saatchigallery #londonart #artgallery #artstudio #artnews #artwork #artist #curator #liveart #newart #guerillaart #photography #weaponry #bomb #ied #performanceart #artfair #artpr #wip #wips #war #warfare (at StudionAme)

[jcowart]

Horse Wall Art Mare On The Salt River Arizona Southwest Horses Equestrian Fine Art Photography Print